Bridgefront Capital’s Nu Skin NUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-13,228
Closed -$96.3K – 673
2026
Q1
$96.3K Buy
+13,228
New +$120K 0.02% 500
2025
Q4
– Sell
-11,548
Closed -$141K – 698
2025
Q3
$141K Buy
+11,548
New +$121K 0.04% 550
2023
Q3
– Sell
-9,129
Closed -$303K – 545
2023
Q2
$303K Buy
9,129
+2,245
+33% +$82.6K 0.16% 241
2023
Q1
$271K Buy
+6,884
New +$286K 0.17% 238

Other funds holding NUS

Bridgefront Capital's NUS Position: Q2 2026 in Review

Bridgefront Capital sold out of Nu Skin (NUS) in Q2 2026, closing a stake of 13,228 shares — an estimated $96.3K sold.

Bridgefront Capital first reported a position in NUS in Q1 2023 and held it in 4 quarters. The position peaked at $303K in Q2 2023. 162 funds tracked by Wall St. Rank hold NUS as of Q2 2026.

  • Bridgefront Capital reported no remaining Nu Skin position as of Q2 2026 after selling out during the quarter.
  • Bridgefront Capital sold 13,228 Nu Skin shares in Q2 2026, an estimated $96.3K.
  • Bridgefront Capital first reported a position in Nu Skin in Q1 2023 and held it in 4 quarters.
  • Bridgefront Capital's Nu Skin position peaked at $303K in Q2 2023.
  • 162 funds tracked by Wall St. Rank held Nu Skin as of Q2 2026.

Based on Bridgefront Capital's 13F filing for Q2 2026, filed 14 Aug 2026.